59 related articles for article (PubMed ID: 21564549)
1. Enzymatic features of the glucose metabolism in tumor cells.
Herling A; König M; Bulik S; Holzhütter HG
FEBS J; 2011 Jul; 278(14):2436-59. PubMed ID: 21564549
[TBL] [Abstract][Full Text] [Related]
2. Chemical Memory with Discrete Turing Patterns Appearing in the Glycolytic Reaction.
Gorecki J; Muzika F
Biomimetics (Basel); 2023 Apr; 8(2):. PubMed ID: 37092406
[TBL] [Abstract][Full Text] [Related]
3. Assessing and utilizing esterase specificity in antimicrobial prodrug development.
Hetrick KJ; Raines RT
Methods Enzymol; 2022; 664():199-220. PubMed ID: 35331374
[TBL] [Abstract][Full Text] [Related]
4. Glucose Metabolism in Burns-What Happens?
Badoiu SC; Miricescu D; Stanescu-Spinu II; Ripszky Totan A; Badoiu SE; Costagliola M; Greabu M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068151
[TBL] [Abstract][Full Text] [Related]
5. Investigation of glucose catabolism in hypoxic Mcf 7 breast cancer culture.
Bayar İ; Bildik A
Cytotechnology; 2021 Apr; 73(2):217-232. PubMed ID: 33927477
[TBL] [Abstract][Full Text] [Related]
6. A New Mathematical Model for Controlling Tumor Growth Based on Microenvironment Acidity and Oxygen Concentration.
Pourhasanzade F; Sabzpoushan SH
Biomed Res Int; 2021; 2021():8886050. PubMed ID: 33575354
[TBL] [Abstract][Full Text] [Related]
7. Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor.
Yang Y; Ji N; Cai CY; Wang JQ; Lei ZN; Teng QX; Wu ZX; Cui Q; Pan Y; Chen ZS
Cancer Commun (Lond); 2020 Jul; 40(7):285-300. PubMed ID: 32525624
[TBL] [Abstract][Full Text] [Related]
8. Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
Ruzzo A; Graziano F; Bagaloni I; Di Bartolomeo M; Prisciandaro M; Aprile G; Ongaro E; Vincenzi B; Perrone G; Santini D; Fornaro L; Vivaldi C; Tomasello G; Loupakis F; Lonardi S; Fassan M; Valmasoni M; Sarti D; Lorenzini P; Catalano V; Bisonni R; Del Prete M; Collina G; Magnani M
Gastric Cancer; 2020 Nov; 23(6):1064-1074. PubMed ID: 32372141
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.
Pajak B; Siwiak E; Sołtyka M; Priebe A; Zieliński R; Fokt I; Ziemniak M; Jaśkiewicz A; Borowski R; Domoradzki T; Priebe W
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905745
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity and glucose tolerance induction by acetyltriethylcitrate, substitute plasticizer compared to di(2-ethylhexyl)phthalate.
Lee JW; Lee SJ; Gye MC; Moon EY
Sci Rep; 2019 Aug; 9(1):12237. PubMed ID: 31439862
[TBL] [Abstract][Full Text] [Related]
11. Cellular Gene Expression during Hepatitis C Virus Replication as Revealed by Ribosome Profiling.
Gerresheim GK; Bathke J; Michel AM; Andreev DE; Shalamova LA; Rossbach O; Hu P; Glebe D; Fricke M; Marz M; Goesmann A; Kiniry SJ; Baranov PV; Shatsky IN; Niepmann M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875926
[TBL] [Abstract][Full Text] [Related]
12. Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.
Zhang YK; Wang YJ; Lei ZN; Zhang GN; Zhang XY; Wang DS; Al-Rihani SB; Shukla S; Ambudkar SV; Kaddoumi A; Shi Z; Chen ZS
Cancer Lett; 2019 Feb; 442():104-112. PubMed ID: 30392788
[TBL] [Abstract][Full Text] [Related]
13. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
De Vera AA; Gupta P; Lei Z; Liao D; Narayanan S; Teng Q; Reznik SE; Chen ZS
Cancer Lett; 2019 Feb; 442():91-103. PubMed ID: 30391357
[TBL] [Abstract][Full Text] [Related]
14. Amino Acid Signature in Human Melanoma Cell Lines from Different Disease Stages.
Wasinger C; Hofer A; Spadiut O; Hohenegger M
Sci Rep; 2018 Apr; 8(1):6245. PubMed ID: 29674683
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Profile of Oral Squamous Carcinoma Cell Lines Relies on a Higher Demand of Lipid Metabolism in Metastatic Cells.
Sant'Anna-Silva ACB; Santos GC; Campos SPC; Oliveira Gomes AM; Pérez-Valencia JA; Rumjanek FD
Front Oncol; 2018; 8():13. PubMed ID: 29456966
[TBL] [Abstract][Full Text] [Related]
16. A Metabolic Therapy for Malignant Glioma Requires a Clinical Measure.
Corbin Z; Spielman D; Recht L
Curr Oncol Rep; 2017 Nov; 19(12):84. PubMed ID: 29098465
[TBL] [Abstract][Full Text] [Related]
17. Fructose-1,6-bisphosphate couples glycolytic flux to activation of Ras.
Peeters K; Van Leemputte F; Fischer B; Bonini BM; Quezada H; Tsytlonok M; Haesen D; Vanthienen W; Bernardes N; Gonzalez-Blas CB; Janssens V; Tompa P; Versées W; Thevelein JM
Nat Commun; 2017 Oct; 8(1):922. PubMed ID: 29030545
[TBL] [Abstract][Full Text] [Related]
18. Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881.
Zhang YK; Zhang XY; Zhang GN; Wang YJ; Xu H; Zhang D; Shukla S; Liu L; Yang DH; Ambudkar SV; Chen ZS
Biochem Pharmacol; 2017 May; 132():29-37. PubMed ID: 28242251
[TBL] [Abstract][Full Text] [Related]
19. Modulatory Role of Shorea robusta Bark on Glucose-metabolizing Enzymes in Diethylnitrosamine Induced Hepatocellular Carcinoma in Rats.
Kalaiselvan A; Anand T; Gokulakrishnan K; Kamaraj MC; Velavan S
Pharmacogn Mag; 2015 Oct; 11(Suppl 3):S496-500. PubMed ID: 26929587
[TBL] [Abstract][Full Text] [Related]
20. Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer.
Graziano F; Ruzzo A; Giacomini E; Ricciardi T; Aprile G; Loupakis F; Lorenzini P; Ongaro E; Zoratto F; Catalano V; Sarti D; Rulli E; Cremolini C; De Nictolis M; De Maglio G; Falcone A; Fiorentini G; Magnani M
Pharmacogenomics J; 2017 Jun; 17(3):258-264. PubMed ID: 26927284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
